JAAD International (Dec 2022)

Long-term follow-up of epidermolysis bullosa in real practice shows stability of the Epidermolysis Bullosa Disease Activity and Scarring Index and improvement with some off-label therapies

  • Genevieve Ho, BMed/MB, MMed,
  • Matthew Gibson, MBBS, MMed, DCH,
  • Nooshafarin Kazemikhoo, MD, PhD,
  • Dedee F. Murrell, MA, BMBCh, MD

Journal volume & issue
Vol. 9
pp. 105 – 107

Abstract

Read online

No abstracts available.

Keywords